Is Abbott Laboratories (ABT) stock a good buy?

This is a step-by-step stock review to answer the question, is Abbott Laboratories (ABT) stock a good buy?

This article will teach you how to use the 4Ms of investing. This will be a detailed walkthrough to show you how the 4Ms work and why they are important. If you are interested, you can log into Tykr to use the 4M Confidence Booster (Powered by OpenAI) which will allow you to complete a 4M Analysis in less than 60 seconds.

What are the 4Ms?

  • MOS (Margin of Safety) – The MOS is the math part of investing which includes the Summary, Score, and MOS (Margin of Safety).
  • Meaning – The meaning is the business model and how scalable the revenue streams are.
  • Moat – The moat is how the business compares to other companies in the same Sector and Industry.
  • Management – The management is the track record of the CEO.

What 4M score are we going for?

  • 80-100 = High confidence – Yay! You should have high confidence buying this stock. It passes all 4M!
  • 60-79 = Moderate confidence – Alert! There may be better stocks in the market. Only buy this stock if you truly believe the company will improve!
  • 0-59 = Low confidence – Warning! There are better stocks in the market. Due to the low score, you should consider looking at other stocks.

Table of Contents

The following links will direct you to key topics to help answer the question, is Abbott Laboratories (ABT) stock a good buy?

  1. Abbott Laboratories Company History
  2. MOS
  3. Meaning
  4. Moat
  5. Management
  6. 4M Score
  7. Is Abbott Laboratories (ABT) stock a good buy?

1. Abbott Laboratories Company History

  • Founded: Abbott Laboratories was established in 1888 by Dr. Wallace C. Abbott in Chicago, Illinois.
  • Early Focus: Initially, the company focused on producing high-quality medicines, starting with a single product, a painkiller made from morphine.
  • Innovation: Abbott was a pioneer in pharmaceutical research and development, introducing the first commercially available insulin in 1922.
  • Expansion: Throughout the 20th century, Abbott expanded its product line to include diagnostics, medical devices, and nutrition products.
  • Global Reach: Today, Abbott operates in over 160 countries, providing a wide range of healthcare solutions, including branded generics, specialty pharmaceuticals, and medical devices.
  • Recent Achievements: In recent years, Abbott has been recognized for its advancements in diabetes care and rapid diagnostic testing, including COVID-19 tests.
  • Mission: Abbott is committed to improving global health through innovative products and solutions, focusing on nutrition, diagnostics, medical devices, and branded generic medicines.

2. MOS (Margin Of Safety)

When investing in a company, the first step is to look at the financials. Fortunately, Tykr does this for us automatically. The higher the score, the stronger the financials and the safer the investment. The higher the MOS, the higher the potential returns you can make.

  • Summary: Overpriced
  • Score: 28
  • MOS: 1%

To see the most up-to-date Summary, Score, and MOS, please log into Tykr.

3. Meaning

When investing in a company, it’s important to know how a company makes money. A mature business model has multiple streams of revenue which allow the company to weather downturns in the economy.

Here is how Abbott Laboratories makes money:

  • Diagnostics: Revenue from tests and equipment for detecting diseases and health conditions.
  • Medical Devices: Earnings from devices used in surgeries, heart care, and other medical procedures.
  • Nutrition Products: Sales of nutritional supplements and specialty foods for various health needs.
  • Branded Generic Medicines: Income from branded versions of generic drugs, often for chronic conditions.
  • Research and Development: Revenue from developing new healthcare products and technologies.
  • Acquisitions: Profits from integrating and expanding through acquisitions of other companies.

Here are a few of the other companies that Abbott Laboratories has acquired over the years. This is important because a company will use a “Buy before build” philosophy to go to market faster and add additional streams of revenue. A company with more revenue streams has a more stable business model. Keep in mind, that most companies don’t build new software because it takes too long to go to market and generate revenue.

  • Alere Inc.
  • St. Jude Medical
  • FreeStyle Libre
  • Abbott Vascular
  • Abbott Diagnostics

4. Moat

When investing in a company, it’s important to understand how a company ranks against other companies in the same sector and industry. Based on the Score, here is how Abbott Laboratories stacks up against other companies.

  1. Stryker Corporation.(SYK) – 89
  2. Edwards Lifesciences Corporation.(EW) – 72
  3. Penumbra, Inc.(PEN) – 72
  4. Globus Medical, Inc.(GMED) – 67
  5. Boston Scientific Corporation.(BSX) – 61
  6. Abbott Laboratories.(ABT) 28

To see the most up-to-date Summary, Score, and MOS and each stock, please log into Tykr.

5. Management

When investing in a company, it’s important to understand who the CEO is, what they have accomplished in the past, and how they have helped this company grow. Good leaders typically have stronger cultures, less turnover, and better returns in the stock market.

  • CEO Appointment (2020): Robert B. Ford Became CEO of Abbott Laboratories, leading the company through a period of significant change and growth.
  • COVID-19 Response: Spearheaded the rapid development and distribution of COVID-19 testing and vaccines, including the successful rollout of the BinaxNOW test.
  • Growth Strategy: Drove expansion into new markets and accelerated growth in key areas like diagnostics, medical devices, and nutrition.
  • Innovation Focus: Oversaw the launch of breakthrough products, enhancing Abbott’s leadership in healthcare technology and patient care.
  • Financial Performance: Guided the company to strong financial results, achieving record revenues and profitability during his tenure.
  • Sustainability Initiatives: Advanced Abbott’s commitment to sustainability and corporate responsibility, improving environmental and social governance practices.
  • Strategic Acquisitions: Led strategic acquisitions that strengthened Abbott’s portfolio and global market presence.

6. 4M Score

All of our homework on this company leads up to the 4M Score. A lot of investors only look at the numbers. Yes, it’s important to look at the first M (MOS) which is the math part of investing but it’s also important to look past the numbers and also look at the Meaning, Moat, and Management. If all 4Ms pass, we should have high confidence in buying this stock.

What 4M score are we going for?

  • 80-100 = High confidence – Yay! You should have high confidence buying this stock. It passes all 4M!
  • 60-79 = Moderate confidence – Alert! There may be better stocks in the market. Only buy this stock if you truly believe the company will improve!
  • 0-59 = Low confidence – Warning! There are better stocks in the market. Due to the low score, you should consider looking at other stocks.

👉 The 4M Score of Abbott Laboratories (ABT) is 58/100.

To see the most up-to-date 4M Score, please log into Tykr.

7. Is Abbott Laboratories (ABT) stock a good buy?

Some of the top questions investors can have is Abbott Laboratories (ABT) stock a good buy or should I buy Abbott Laboratories (ABT) stock?

Abbott Laboratories (ABT) is a strong investment choice for several reasons. The company boasts a diversified portfolio, including diagnostics, medical devices, and nutritional products, which provides stability and growth potential. Abbott’s innovative approach has led to the successful launch of breakthrough products, such as the BinaxNOW COVID-19 test, showcasing its ability to address critical health needs. The company’s consistent revenue growth and strong financial performance underscore its market leadership. Additionally, Abbott’s strategic focus on expanding its global presence and investing in cutting-edge technology supports its long-term growth prospects. However, investors should consider potential risks such as regulatory challenges and market competition. Overall, Abbott Laboratories’ diverse product range, innovation-driven growth, and solid financial performance make it a compelling investment in the healthcare sector.

To truly know if Abbott Laboratories is a good stock to buy or sell, we recommend you log into Tykr. Within seconds you can see the Summary, Score, MOS, and 4M Score.

If you found this stock review interesting, you may also like this review on AMD.